https://www.selleckchem.com/pr....oducts/bms-986205.ht
Cancer is often complicated by the deterioration of both muscle mass and function, which may be more pronounced in older people. The prevalence of sarcopenia varies according to tumour type, stage and sarcopenia definition; in gynaecologic malignancies it ranges from 25 to 50%. Unfortunately, sarcopenia is often underdiagnosed especially in overweight and obese patients. The consequences of sarcopenia are serious shorter time of tumour progression, increased chemotherapy-related toxicity, post-operative complications, poor functional
Like
Comment
Share
